Sun Young Jeong, Aiyu Chen, Yi-Lin Wu, Ming-Sum Lee
{"title":"心悸患者的评估和临床结果中的性别和年龄差异。","authors":"Sun Young Jeong, Aiyu Chen, Yi-Lin Wu, Ming-Sum Lee","doi":"10.1007/s11606-024-08860-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Palpitations represent a common clinic complaint.</p><p><strong>Objective: </strong>To explore gender and age differences in the evaluation and outcomes of patients with palpitations in outpatient settings.</p><p><strong>Design/participants: </strong>This is a retrospective observational study of 58,543 patients with no known structural cardiac disease or arrythmias presenting to primary care and cardiology clinics in an integrated health system in California with palpitations between January 2017 and December 2021. The primary and secondary endpoints were hospitalization for arrhythmia and all-cause mortality at 1 year. Multivariable logistic regression models evaluated the association between gender, age, and outcomes.</p><p><strong>Results: </strong>Men and women were equally as likely to be started on beta-blockers (adjusted OR 0.96, 95% CI 0.90-1.02) and evaluated with electrocardiograms (adjusted OR 0.95, 95% CI 0.90-1.01) and cardiac monitors (adjusted OR 1.04, 95% CI 0.99-1.08). Patients who completed Holter or event monitors had a lower rate of hospitalization for cardiovascular disease at 1 year than those without (2.3% vs. 2.7%, p = 0.001). At 1 year, women had a lower risk of all-cause mortality (adjusted OR 0.47, 95% CI 0.35-0.64) and hospitalization for atrial fibrillation (adjusted OR 0.47, 95% CI 0.30-0.72) and arrhythmias (adjusted OR 0.73, 95% CI 0.58-0.91) compared to men. Among older women and men (≥ 80 years), there was no significant difference in 1-year all-cause mortality (adjusted OR 0.57, 95% CI 0.29-1.12), hospitalization for atrial fibrillation (adjusted OR 0.58, 95% CI 0.17-1.97), or arrhythmias (adjusted OR 1.15, 95% CI 0.12-11.07).</p><p><strong>Conclusions: </strong>There were no gender differences in referrals for cardiac monitoring or prescriptions for beta-blockers. Women had a better prognosis with a lower risk of hospitalization for arrhythmias and death at 1 year compared to men. However, 1-year risks for mortality and hospitalization for arrythmias among older women were comparable to those of older men, underscoring the importance of considering age and gender in managing patients with palpitations.</p>","PeriodicalId":15860,"journal":{"name":"Journal of General Internal Medicine","volume":" ","pages":"3035-3041"},"PeriodicalIF":4.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576712/pdf/","citationCount":"0","resultStr":"{\"title\":\"Gender and Age Differences in the Evaluation and Clinical Outcomes of Patients with Palpitations.\",\"authors\":\"Sun Young Jeong, Aiyu Chen, Yi-Lin Wu, Ming-Sum Lee\",\"doi\":\"10.1007/s11606-024-08860-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Palpitations represent a common clinic complaint.</p><p><strong>Objective: </strong>To explore gender and age differences in the evaluation and outcomes of patients with palpitations in outpatient settings.</p><p><strong>Design/participants: </strong>This is a retrospective observational study of 58,543 patients with no known structural cardiac disease or arrythmias presenting to primary care and cardiology clinics in an integrated health system in California with palpitations between January 2017 and December 2021. The primary and secondary endpoints were hospitalization for arrhythmia and all-cause mortality at 1 year. Multivariable logistic regression models evaluated the association between gender, age, and outcomes.</p><p><strong>Results: </strong>Men and women were equally as likely to be started on beta-blockers (adjusted OR 0.96, 95% CI 0.90-1.02) and evaluated with electrocardiograms (adjusted OR 0.95, 95% CI 0.90-1.01) and cardiac monitors (adjusted OR 1.04, 95% CI 0.99-1.08). Patients who completed Holter or event monitors had a lower rate of hospitalization for cardiovascular disease at 1 year than those without (2.3% vs. 2.7%, p = 0.001). At 1 year, women had a lower risk of all-cause mortality (adjusted OR 0.47, 95% CI 0.35-0.64) and hospitalization for atrial fibrillation (adjusted OR 0.47, 95% CI 0.30-0.72) and arrhythmias (adjusted OR 0.73, 95% CI 0.58-0.91) compared to men. Among older women and men (≥ 80 years), there was no significant difference in 1-year all-cause mortality (adjusted OR 0.57, 95% CI 0.29-1.12), hospitalization for atrial fibrillation (adjusted OR 0.58, 95% CI 0.17-1.97), or arrhythmias (adjusted OR 1.15, 95% CI 0.12-11.07).</p><p><strong>Conclusions: </strong>There were no gender differences in referrals for cardiac monitoring or prescriptions for beta-blockers. Women had a better prognosis with a lower risk of hospitalization for arrhythmias and death at 1 year compared to men. However, 1-year risks for mortality and hospitalization for arrythmias among older women were comparable to those of older men, underscoring the importance of considering age and gender in managing patients with palpitations.</p>\",\"PeriodicalId\":15860,\"journal\":{\"name\":\"Journal of General Internal Medicine\",\"volume\":\" \",\"pages\":\"3035-3041\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576712/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of General Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11606-024-08860-1\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of General Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11606-024-08860-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
背景:心悸是常见的临床主诉:心悸是一种常见的门诊主诉:探讨门诊心悸患者在评估和治疗结果方面的性别和年龄差异:这是一项回顾性观察研究,研究对象是 2017 年 1 月至 2021 年 12 月期间因心悸到加利福尼亚州一家综合医疗系统的初级保健和心脏病诊所就诊的 58543 名无已知结构性心脏病或心律失常的患者。主要和次要终点为心律失常住院率和一年内全因死亡率。多变量逻辑回归模型评估了性别、年龄和结果之间的关联:男性和女性开始使用β-受体阻滞剂(调整后 OR 0.96,95% CI 0.90-1.02)以及接受心电图(调整后 OR 0.95,95% CI 0.90-1.01)和心脏监护仪(调整后 OR 1.04,95% CI 0.99-1.08)评估的可能性相同。完成 Holter 或事件监测的患者 1 年后因心血管疾病住院的比例低于未完成 Holter 或事件监测的患者(2.3% 对 2.7%,P = 0.001)。1 年后,与男性相比,女性的全因死亡率(调整后 OR 0.47,95% CI 0.35-0.64)和因心房颤动(调整后 OR 0.47,95% CI 0.30-0.72)和心律失常(调整后 OR 0.73,95% CI 0.58-0.91)住院的风险较低。在老年女性和男性(≥ 80 岁)中,1 年全因死亡率(调整后 OR 0.57,95% CI 0.29-1.12)、心房颤动住院率(调整后 OR 0.58,95% CI 0.17-1.97)或心律失常率(调整后 OR 1.15,95% CI 0.12-11.07)没有显著差异:在转诊接受心脏监测或开具β-受体阻滞剂处方方面没有性别差异。与男性相比,女性的预后较好,因心律失常住院和一年后死亡的风险较低。不过,老年女性一年后因心律失常住院和死亡的风险与老年男性相当,这说明在管理心悸患者时考虑年龄和性别因素非常重要。
Gender and Age Differences in the Evaluation and Clinical Outcomes of Patients with Palpitations.
Background: Palpitations represent a common clinic complaint.
Objective: To explore gender and age differences in the evaluation and outcomes of patients with palpitations in outpatient settings.
Design/participants: This is a retrospective observational study of 58,543 patients with no known structural cardiac disease or arrythmias presenting to primary care and cardiology clinics in an integrated health system in California with palpitations between January 2017 and December 2021. The primary and secondary endpoints were hospitalization for arrhythmia and all-cause mortality at 1 year. Multivariable logistic regression models evaluated the association between gender, age, and outcomes.
Results: Men and women were equally as likely to be started on beta-blockers (adjusted OR 0.96, 95% CI 0.90-1.02) and evaluated with electrocardiograms (adjusted OR 0.95, 95% CI 0.90-1.01) and cardiac monitors (adjusted OR 1.04, 95% CI 0.99-1.08). Patients who completed Holter or event monitors had a lower rate of hospitalization for cardiovascular disease at 1 year than those without (2.3% vs. 2.7%, p = 0.001). At 1 year, women had a lower risk of all-cause mortality (adjusted OR 0.47, 95% CI 0.35-0.64) and hospitalization for atrial fibrillation (adjusted OR 0.47, 95% CI 0.30-0.72) and arrhythmias (adjusted OR 0.73, 95% CI 0.58-0.91) compared to men. Among older women and men (≥ 80 years), there was no significant difference in 1-year all-cause mortality (adjusted OR 0.57, 95% CI 0.29-1.12), hospitalization for atrial fibrillation (adjusted OR 0.58, 95% CI 0.17-1.97), or arrhythmias (adjusted OR 1.15, 95% CI 0.12-11.07).
Conclusions: There were no gender differences in referrals for cardiac monitoring or prescriptions for beta-blockers. Women had a better prognosis with a lower risk of hospitalization for arrhythmias and death at 1 year compared to men. However, 1-year risks for mortality and hospitalization for arrythmias among older women were comparable to those of older men, underscoring the importance of considering age and gender in managing patients with palpitations.
期刊介绍:
The Journal of General Internal Medicine is the official journal of the Society of General Internal Medicine. It promotes improved patient care, research, and education in primary care, general internal medicine, and hospital medicine. Its articles focus on topics such as clinical medicine, epidemiology, prevention, health care delivery, curriculum development, and numerous other non-traditional themes, in addition to classic clinical research on problems in internal medicine.